| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 271.00M | 241.00M | 220.00M | 227.00M | 197.00M | 81.00M |
| Gross Profit | 211.00M | 170.00M | 172.00M | 178.00M | 146.00M | 47.00M |
| EBITDA | -5.39B | 5.74B | 4.75B | -9.23B | 6.36B | 3.30B |
| Net Income | -5.39B | 5.74B | 4.75B | -9.24B | 6.35B | 3.29B |
Balance Sheet | ||||||
| Total Assets | 20.67B | 24.74B | 19.19B | 14.64B | 24.00B | 17.93B |
| Cash, Cash Equivalents and Short-Term Investments | 335.00M | 782.00M | 1.58B | 532.00M | 459.00M | 1.46B |
| Total Debt | 253.00M | 3.00M | 3.00M | 3.00M | 4.00M | 3.00M |
| Total Liabilities | 273.00M | 52.00M | 57.00M | 95.00M | 48.00M | 232.30M |
| Stockholders Equity | 20.39B | 24.68B | 19.12B | 14.54B | 23.94B | 17.68B |
Cash Flow | ||||||
| Free Cash Flow | 190.00M | 172.00M | 1.37B | 160.00M | 958.00M | 45.00M |
| Operating Cash Flow | 426.00M | 172.00M | 1.37B | 176.00M | 980.00M | 48.00M |
| Investing Cash Flow | -778.00M | -778.00M | -124.00M | 39.00M | -1.67B | -455.00M |
| Financing Cash Flow | 46.00M | -201.00M | -206.00M | -125.00M | -151.00M | 916.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | kr9.78B | 7.54 | 12.47% | 2.21% | 4.72% | -38.28% | |
70 Neutral | kr11.92B | 14.40 | 6.59% | 3.74% | -22.65% | -14.05% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | kr7.85B | 39.28 | 15.16% | ― | 11.30% | -14.49% | |
59 Neutral | kr22.58B | 180.66 | 0.33% | ― | -97.64% | ― | |
58 Neutral | kr17.93B | -3.32 | -23.18% | 1.14% | 22.38% | -153.85% | |
56 Neutral | €22.58B | 181.82 | ― | ― | -97.64% | ― |
Bure Equity AB has announced an increase in its total number of shares and votes, following the issuance and immediate repurchase of 144,562 C shares under its LTIP 2025 incentive program. This change reflects a strategic move to adjust its share capital and voting rights, with the total number of shares now at 74,646,317 and votes at 74,240,396, potentially impacting shareholder value and company governance.
Bure Equity AB has announced the issuance and immediate re-purchase of 144,562 class C shares as part of their LTIP 2025 incentive program. This move ensures the delivery of shares to participants and secures social contributions, with the class C shares being converted into ordinary shares before distribution.
Bure Equity AB, a Swedish investment company, reported a challenging financial performance for the first nine months of 2025, with a 17.5% decrease in net asset value per share and a total return on shares of -26.7%. Despite some stabilization in the third quarter, the company faced currency struggles and lower growth, impacting its portfolio companies. Key activities included the acquisition of a stake in Silex Microsystems and divestments in Mycronic and Ovzon. The CEO noted both positive developments in companies like Vitrolife and challenges such as Yubico’s unmet expectations.
Bure Equity AB has announced a change in its share structure due to the conversion of class C shares into ordinary shares. This adjustment, aimed at fulfilling the company’s long-term incentive program, slightly alters the distribution of shares and votes, reflecting Bure’s ongoing commitment to its strategic initiatives.
Bure Equity AB has announced the formation of its Nominating Committee for the 2026 annual general meeting, comprising representatives from its largest shareholders and the Chairman of the Board. This committee, representing 36.4% of voting shares, will play a crucial role in shaping the company’s governance and strategic direction ahead of the meeting scheduled for May 2026.